Photo Credit: Video Call At Night With Colleagues by Jacob Lund Photography from NounProject.com

Videos

 

  • A Hitchhicker Guide to Hematopoetic Stem Cell Transplant (HSCT) for Autoimmune Disease

    A Hitchhicker Guide to Hematopoetic Stem Cell Transplant (HSCT) for Autoimmune Disease

    Neurology Grand Rounds at the University of Minnesota Medical School - Richard K Burt MD, Feinberg School of Medicine, Northwestern University - February 22, 2019.

  • Prof Richard K. Burt – ‘Haemopoietic stem cell transplantation in the management of MS’

    Prof Richard K. Burt - 'Haemopoietic stem cell transplantation in the management of MS'

    This video is about Haemopoietic stem cell transplantation in the management of multiple sclerosis.

  • Clinica Ruiz – Mexico – HSCT Administrative Video

    Clinica Ruiz - Mexico - HSCT Administrative Video

    Autologous Hematopoietic Stem Cell Transplant is a treatment for autoimmune diseases such as MS-Multiple Sclerosis (SPMS), (PPMS) or (RRMS), Scleroderma, Type I Diabetes, CIDP-Chronic Inflammatory Demyelinating Polyneuropathy, TM-Transverse Myelitis or NMO-Neuromyelitis Optica, that has scientifically proven to halt the disease progression. Hematopoietic stem cells are used to restore the normal hematopoiesis of the patient after being exposed to high dose chemotherapy delivered to aim immunosuppression.

  • Dr. Richard Burt: Hematopoietic Stem Cell Transplantation

    Dr. Richard Burt: Hematopoietic Stem Cell Transplantation

    2018 Fall Patient Education Conference
    Hematopoietic Stem Cell Transplantation

    Richard Burt, MD
    Chief of Immunotherapy and Autoimmune Diseases, Professor of Medicine, Division of Immunotherapy and Autoimmune Diseases; Northwestern University, Feinberg School of Medicine, Chicago, IL

    Presented at the Scleroderma Patient Education Conference 2018.

    Hosted by the Scleroderma Foundation Greater Chicago Chapter.

    More Information on Official Website and YouTube: www.scleroderma.org/chicago

  • Stem Cells in Multiple Sclerosis

    Stem Cells in Multiple Sclerosis

    Dr. Daniel Kantor, Shirley Nedzesky, & Wendy Booker speak with Mark Freedman from the University of Ottowa about the current status of Stem Cell research in the field of Multiple Sclerosis.

  • EBMT 2018 – Dr. Richard Burt Day 3 Presentation

    EBMT 2018 - Dr. Richard Burt Day 3 Presentation

    Dr. Richard Burt of Northwestern University, Chicago at the Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on 18-21 March 2018 held at Lisbon, Portugal.

    Day 3 Presentation titled: A Hitchhiker Guide to HSCT for Autoimmune Disease: Don't Panic Multiple Sclerosis

  • EBMT 2018 – Dr. Richard Burt Day 1 Presentation

    EBMT 2018 - Dr. Richard Burt Day 1 Presentation

    Dr. Richard Burt of Northwestern University, Chicago at the Annual Meeting of the European Society for Blood and Marrow Transplantation on 18-21 March 2018 held at Lisbon, Portugal.

    Day 1 Presentation titled: Non-Myeloablative Haematopoietic Stem Cell Transplantation Versus Continued Disease Modifying Therapies (DMT) in Patients With Highly Active Relapsing Remitting Multiple Sclerosis (RRMS)

    Richard K Burt, Roumen Balabanov, John A Snowden, Basil Sharrack, Maria Carolina Oliveira, Flavia Nelson, Joachim Burman (United States)

  • EBMT 2018 – Dr. Richard Burt received Van Bekkum Award

    EBMT 2018 - Dr. Richard Burt received Van Bekkum Award

    Dr. Richard Burt of Northwestern University, Chicago received Van Bekkum Award at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on 18-21 March 2018 held at Lisbon, Portugal. The Van Bekkum Award is the most prestigious EBMT award for the best abstract submitted to the physician's programme and is selected by the EBMT Board. The winning abstract will be presented as part of the Opening Session of the Meeting.

  • Cellular Horizons Day 2 – Using Adult Stem Cells to Treat Autoimmune Disorders

    Cellular Horizons Day 2 - Using Adult Stem Cells to Treat Autoimmune Disorders

    Cellular Horizons: How Science , Technology, Information and Communication Will Impact Society, Vatican City, April 28-30, 2016.

    Day 2: Cellular and Technological Breakthroughs in Cancer, April 29, 2016.

    Sanjay Gupta, MD, moderates a discussion with Richard K. Burt, MD, Chief of the Division of Immunotherapy, Department of Medicine, Northwestern University Feinberg School of Medicine, and two of his patients, Elizabeth Cougentakis and Grace Meihaus.

  • Northwestern Medicine HSCT Graft-Versus-Host Disease

    Northwestern Medicine HSCT Graft-Versus-Host Disease

  • Northwestern Medicine HSCT Post-Transplant

    Northwestern Medicine HSCT Post-Transplant

  • Northwestern Medicine The Inpatient Stay

    Northwestern Medicine The Inpatient Stay

  • Northwestern Medicine HSCT Harvest Process

    Northwestern Medicine HSCT Harvest Process

  • Northwestern Medicine HSCT Pre-Transplant Process

    Northwestern Medicine HSCT Pre-Transplant Process

  • Northwestern Medicine HSCT Program Overview

    Northwestern Medicine HSCT Program Overview